Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05376215 · ClinicalTrials.gov registry record · NA

A Comparison of Hearing Aid Fitting Methods

A NA study of Hearing Loss, sponsored by Sonova.

Completed
Registry status
NA
Development phase
44
Enrollment target
1
Study location

NCT05376215: Completed NA study of Hearing Loss, sponsored by Sonova.

NCT05376215 is a NA study of Hearing Loss that has completed, run by Sonova. The registered enrollment target is 44 participants, below the 6,120-participant average among 58 other Hearing Loss trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05376215, a NA study of Hearing Loss, has completed, sponsored by Sonova.

COMPLETED
Registry status
NA
Development phase
44 participants
Enrollment target
1
Study location

Study Summary

This investigation will compare hearing aid fitting methods between self-fitting and clinician fitting approaches by using a standardized questionnaire to evaluate subjective hearing aid benefit.

Primary Outcome

A validated questionnaire that assesses the subjective benefit of hearing aids in daily life. Participants rate their difficulty hearing in different situations, going from Always (99%), Almost Always (87%), Generally (75%), Half the time (50%), Occasionally (25%), Seldom (12%) or Never (1%). For example, the participant may choose "Always" to the statement "When I am having a quiet conversation with a friend, I have difficulty understanding". The questions are categorized into 4 different sub-s

Conditions Studied

Hearing Loss

Interventions

  • DEVICE Experimental hearing aid

Study Locations (1)

Florida

  • University of South Florida - Tampa

Trial Details

FieldValue
Enrollment Target 44 participants
Start Date 2022-08-17
Est. Completion 2022-12-08
Phase NA
Sonova

29 total trials

What the finished NCT05376215 record still lists

NCT05376215 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 6,120-participant average among 58 other Hearing Loss trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Hearing Loss appearing as the primary indexed condition, and to 1 intervention - of which Experimental hearing aid is the first listed.

NCT05376215 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT05376215 about?

NCT05376215 is a clinical study titled "A Comparison of Hearing Aid Fitting Methods". This investigation will compare hearing aid fitting methods between self-fitting and clinician fitting approaches by using a standardized questionnaire to evaluate subjective hearing aid benefit.

What is the current status of trial NCT05376215?

This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2022-08-17. Estimated completion is 2022-12-08.

What conditions does trial NCT05376215 study?

This clinical trial studies the following conditions: Hearing Loss.

What interventions are being tested in trial NCT05376215?

The interventions under investigation include: Experimental hearing aid (DEVICE).

Who is sponsoring clinical trial NCT05376215?

This trial is sponsored by Sonova, which has 29 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05376215 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Hearing Loss

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05376215's enrollment target sits among peer trials

44 43rd of 58 higher than 15 of 58 other Hearing Loss trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hearing Loss trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02323945 · 44 participants · NA

    Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury

  • NCT03093909 · 44 participants · Phase 1

    Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases

  • NCT03104491 · 44 participants · Phase 1

    Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia

  • NCT03781765 · 44 participants · Phase 4

    Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT05376215, the US trial registry maintained by the National Library of Medicine. NCT05376215 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.